Public

Journal of Pharmacy Quality Improvement Initiatives (PharmQIIs)

Date: 24 July 2026 - 9:27am

The Journal of Pharmacy Quality Improvement Initiatives (PharmQIIs) is a peer-reviewed journal published by the Pharmaceutical Services Programme (PSP), Ministry of Health Malaysia (MOH). This journal is one of our initiatives to share best practices and practical knowledge when conducting Quality Improvement Initiatives (QIIs). Thus, it will encourage and motivate more pharmacy professionals to take part in quality-based improvement initiatives to contribute and provide better health care services.

English

National Oncology Pharmacy Conference 2023

Location/place: 
Institut Kanser Negara
Date: 
Wednesday, 15 March 2023 to Friday, 17 March 2023

FREQUENTLY ASKED QUESTIONS (FAQS) RELATED TO LICENSING ACTIVITIES WITH THE ENFORCEMENT OF THE POISONS (AMENDMENT) ACT 2022

These FAQs are in line with the enforcement of the Poisons (Amendment) Act 2022 and act as a reference for all licensed pharmacists and registered pharmacists.

If you have any enquiries, please email us at pelesenanbpf@moh.gov.my.

Position Statements on the Use of Biosimilars in the Ministry of Health, Malaysia Healthcare Facilities

Date: 15 October 2023 - 5:21am

The increasing use of biological medicines including biosimilars in the Ministry of Health (MOH), Malaysia facilities warrants a suitable guidance document to ensure safe

English

#MedSafetyWeek 2022

During the annual #MedSafetyWeek global campaign, National Pharmaceutical Regulatory Agency (NPRA) collaborates with the Uppsala Monitoring Centre (UMC, the World Health Organisation (WHO) Collaborating Centre for International Drug Monitoring), medicines regulatory authorities, and national pharmacovigilance centres around the world to raise awareness of medication safety and encourage reporting of suspected adverse drug reactions/adverse events following immunisation (ADR/AEFI).

Location/place: 
Online
Date: 
Monday, 7 November 2022 to Sunday, 13 November 2022

PENGUMUMAN: GARIS PANDUAN KELULUSAN PENGIKLANAN PRODUK BERDAFTAR

Date: 15 October 2023 - 5:21am

Garis Panduan ini adalah digunakan sebagai rujukan/panduan tentang perkara-perkara yang harus dipatuhi dalam merangka iklan produk ubat berdaftar untuk kelulusan Lembaga Iklan Ubat. Garis Panduan ini akan mengganti Garis Panduan Pengiklanan Ubat dan Produk Perubatan kepada Orang Ramai. Tarikh penguatkuasaan garis panduan ini adalah pada 1 Oktober 2022.  

Sekiranya tuan/puan mempunyai sebarang pertanyaan lanjut, sila hubungi Sekretariat Lembaga Iklan Ubat di talian 03-78413200 atau melalui emel liu@moh.gov.my.
 

Medicine Advertisements Board (MAB) Guidelines And Policy

Date: 15 June 2026 - 10:29am

These Guidelines are intended to complement the provisions of the Medicines (Advertisement and Sale) Act 1956 (Revised 1983) and the Medicine Advertisements Board Regulations 1976.

Advertisements include any notice, circular, report, commentary, pamphlet, label, wrapper or other document, and any announcement made orally or by any means of producing or transmitting light or sound.

English

Pages